ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/09/06 | 1,715 | 1,725 | 1,640 | 1,693 | -45 | -2.6% | 1,597,700 |
2018/09/05 | 1,780 | 1,849 | 1,736 | 1,738 | -19 | -1.1% | 3,892,400 |
2018/09/04 | 1,656 | 1,818 | 1,653 | 1,757 | +116 | +7.1% | 4,098,100 |
2018/09/03 | 1,702 | 1,730 | 1,626 | 1,641 | -61 | -3.6% | 1,294,200 |
2018/08/31 | 1,633 | 1,720 | 1,621 | 1,702 | +43 | +2.6% | 1,352,200 |
2018/08/30 | 1,700 | 1,709 | 1,622 | 1,659 | -33 | -2% | 1,589,100 |
2018/08/29 | 1,674 | 1,710 | 1,633 | 1,692 | +7 | +0.4% | 1,521,200 |
2018/08/28 | 1,725 | 1,820 | 1,611 | 1,685 | -39 | -2.3% | 5,134,000 |
2018/08/27 | 1,543 | 1,730 | 1,532 | 1,724 | +185 | +12% | 3,467,300 |
2018/08/24 | 1,471 | 1,560 | 1,436 | 1,539 | +75 | +5.1% | 2,180,800 |
2018/08/23 | 1,424 | 1,527 | 1,421 | 1,464 | +51 | +3.6% | 2,480,600 |
2018/08/22 | 1,388 | 1,422 | 1,367 | 1,413 | +18 | +1.3% | 780,400 |
2018/08/21 | 1,300 | 1,403 | 1,300 | 1,395 | +85 | +6.5% | 1,329,400 |
2018/08/20 | 1,295 | 1,345 | 1,291 | 1,310 | +45 | +3.6% | 1,256,400 |
2018/08/17 | 1,244 | 1,274 | 1,236 | 1,265 | +51 | +4.2% | 861,900 |
2018/08/16 | 1,201 | 1,233 | 1,185 | 1,214 | -11 | -0.9% | 962,700 |
2018/08/15 | 1,246 | 1,264 | 1,205 | 1,225 | -12 | -1% | 1,006,700 |
2018/08/14 | 1,273 | 1,279 | 1,213 | 1,237 | -18 | -1.4% | 1,520,000 |
2018/08/13 | 1,350 | 1,355 | 1,250 | 1,255 | -114 | -8.3% | 2,099,600 |
2018/08/10 | 1,440 | 1,474 | 1,363 | 1,369 | ±0 | ±0% | 2,071,400 |
2018/08/09 | 1,366 | 1,385 | 1,358 | 1,369 | -2 | -0.1% | 401,000 |
2018/08/08 | 1,401 | 1,401 | 1,366 | 1,371 | -35 | -2.5% | 622,500 |
2018/08/07 | 1,380 | 1,421 | 1,371 | 1,406 | +25 | +1.8% | 923,100 |
2018/08/06 | 1,374 | 1,397 | 1,368 | 1,381 | +12 | +0.9% | 607,800 |
2018/08/03 | 1,374 | 1,406 | 1,367 | 1,369 | -5 | -0.4% | 764,800 |
2018/08/02 | 1,378 | 1,404 | 1,366 | 1,374 | -2 | -0.1% | 533,800 |
2018/08/01 | 1,396 | 1,411 | 1,376 | 1,376 | -20 | -1.4% | 563,300 |
2018/07/31 | 1,371 | 1,399 | 1,367 | 1,396 | +15 | +1.1% | 504,300 |
2018/07/30 | 1,422 | 1,437 | 1,377 | 1,381 | -41 | -2.9% | 799,500 |
2018/07/27 | 1,393 | 1,429 | 1,375 | 1,422 | +32 | +2.3% | 612,100 |
2018/07/26 | 1,408 | 1,432 | 1,371 | 1,390 | -26 | -1.8% | 1,067,700 |
2018/07/25 | 1,429 | 1,475 | 1,406 | 1,416 | -19 | -1.3% | 1,116,300 |
2018/07/24 | 1,355 | 1,475 | 1,355 | 1,435 | +104 | +7.8% | 3,203,400 |
2018/07/23 | 1,336 | 1,352 | 1,325 | 1,331 | +2 | +0.2% | 602,100 |
2018/07/20 | 1,336 | 1,369 | 1,308 | 1,329 | -20 | -1.5% | 1,310,200 |
2018/07/19 | 1,403 | 1,405 | 1,338 | 1,349 | -35 | -2.5% | 728,300 |
2018/07/18 | 1,376 | 1,397 | 1,365 | 1,384 | +8 | +0.6% | 812,300 |
2018/07/17 | 1,392 | 1,398 | 1,366 | 1,376 | -36 | -2.5% | 540,800 |
2018/07/13 | 1,420 | 1,423 | 1,395 | 1,412 | -2 | -0.1% | 703,700 |
2018/07/12 | 1,395 | 1,456 | 1,388 | 1,414 | +32 | +2.3% | 750,500 |
2018/07/11 | 1,414 | 1,424 | 1,342 | 1,382 | -32 | -2.3% | 886,400 |
2018/07/10 | 1,409 | 1,455 | 1,409 | 1,414 | +2 | +0.1% | 903,500 |
2018/07/09 | 1,425 | 1,442 | 1,403 | 1,412 | +25 | +1.8% | 841,100 |
2018/07/06 | 1,363 | 1,413 | 1,340 | 1,387 | +54 | +4.1% | 2,133,600 |
2018/07/05 | 1,427 | 1,479 | 1,304 | 1,333 | -115 | -7.9% | 3,230,000 |
2018/07/04 | 1,466 | 1,504 | 1,433 | 1,448 | -26 | -1.8% | 1,180,500 |
2018/07/03 | 1,581 | 1,596 | 1,414 | 1,474 | -110 | -6.9% | 2,973,700 |
2018/07/02 | 1,771 | 1,774 | 1,584 | 1,584 | -200 | -11.2% | 1,872,700 |
2018/06/29 | 1,745 | 1,784 | 1,734 | 1,784 | +51 | +2.9% | 488,100 |
2018/06/28 | 1,775 | 1,779 | 1,729 | 1,733 | -59 | -3.3% | 435,600 |
1651~
1700
件表示中 / 5113件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 89,500円 | +20.3% | - | 0.00% | 158.69倍 | 1.18倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 148,200円 | -2.4% | -52.3% | 3.85% | 17.74倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 211,000円 | +4.1% | -3.1% | 2.75% | 18.38倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ハートシード | 346,000円 | +174.2% | - | 0.00% | - | 10.38倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
JCRファーマ | 54,800円 | +14.3% | - | 3.65% | 22.26倍 | 1.42倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム